ImmunityBio (IBRX) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for ImmunityBio, as the data feed reports them.

Analysts' mean target, 4 analysts
$14.25
127.6% above the price

The 4 analysts reported by the data feed have a mean price target for ImmunityBio of $14.25, 127.6% above the $6.26 price (range $12.00–$16.00). 31.14% of the float was sold short as of Oct 30, 2026. Institutions hold 20.0% of the shares and insiders 61.9%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$14.25+127.6% vs price
Analysts
4
Short interest
31.14%of float, Oct 30, 2026
Short ratio
8.32 days
Institutions
20.0%
Insiders
61.92%
Beta
0.17

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

4 analysts covering ImmunityBio, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $6.26.

Analysts' price targets for ImmunityBio
Mean price target$14.25127.6% above the price (+127.6%)
Median price target$14.50131.6% above the price (+131.6%)
Highest target$16.00155.6% above the price (+155.6%)
Lowest target$12.0091.7% above the price (+91.7%)
Analysts with a target4

Ratings this month · 4 analysts

Strong buy 1(25%)Buy 3(75%)
Analysts' ratings of ImmunityBio this month, by rating
RatingAnalystsShare
Strong buy125%
Buy375%
Hold00%
Sell00%
Strong sell00%

The feed averages these to 1.25 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns ImmunityBio

Ownership of ImmunityBio
Held by institutions20.0%512 institutions; percent of shares outstanding
Held by institutions, of the float52.4%
Held by insiders61.92%percent of shares outstanding
Shares outstanding1.06B
Float410.68Mshares available to trade
Insiders' net purchases, six months−173.34K4 purchases (368.16K shares), 7 sales (541.5K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in ImmunityBio
Shares short126.08Mas of Oct 30, 2026
Percent of float31.14%shares short ÷ float
Percent of shares outstanding11.85%shares short ÷ shares outstanding
Short ratio (days to cover)8.32shares short ÷ average daily volume

ImmunityBio short interest from FINRA, with its history

Trading figures

Trading figures for ImmunityBio
Beta0.17movement against the market; 1 moves with it
52-week high$12.43
52-week low$1.95
Average volume, 3 months12.74Mshares a day
Average volume, 10 days16.18Mshares a day

Questions and answers

What is the analysts' price target for ImmunityBio (IBRX)?

As reported by the data feed, the mean price target of the 4 analysts covering ImmunityBio is $14.25, 127.6% above the latest price of $6.26. The highest target is $16.00 and the lowest $12.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate ImmunityBio stock?

Of the 4 ratings the data feed reports for the current month, 1 are strong buy, 3 buy, 0 hold, 0 sell and 0 strong sell.

How many ImmunityBio shares are sold short?

As reported by the data feed, 126.08M shares were sold short, 31.14% of the float as of Oct 30, 2026. At the average daily volume that is 8.32 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns ImmunityBio stock?

As reported by the data feed, institutions hold 20.0% of the shares (512 institutions) and insiders 61.9%. There are 1.06B shares outstanding, of which 410.68M are in the float.

How much does ImmunityBio stock move with the market?

Its beta, as reported by the data feed, is 0.17: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $1.95 and $12.43.

Cite this page

Funkfolio, “ImmunityBio (IBRX) statistics: analyst targets and short interest”, data as of 17 November 2026. https://funkfolio.com/stock/IBRX/statistics

Underlying data: Yahoo Finance.